Jarad Levin, MD
Dermatology · Oklahoma City, OKNPI 1407177538
Payments from drug & device makers
Across 223 payments — averaging $5504.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$389K
- Boehringer Ingelheim$311K
- Novartis$150K
- Pfizer$143K
- Amgen$60K
- Incyte Corporation$43K
- plus $132K from 27 others
Across 7 payments — averaging $2890.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$20K
What the payments were for
- Travel & lodging$96116%
- Food & beverage$4,82478%
- Education$3606%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 16 | $388,551 |
| Boehringer Ingelheim | 25 | $311,440 |
| Novartis | 11 | $149,504 |
| Pfizer | 33 | $143,064 |
| Amgen | 9 | $60,116 |
| Incyte Corporation | 8 | $42,505 |
| GSK | 16 | $39,598 |
| Janssen Research & Development, LLC | 5 | $31,080 |
| AbbVie | 10 | $20,864 |
| Sanofi US Services Inc. | 1 | $13,490 |
| Galderma Laboratories, L.p. | 7 | $10,347 |
| Boehringer Ingelheim Espana S.A. | 4 | $4,009 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 1 | $3,114 |
| Boehringer Ingelheim International GmbH | 3 | $3,026 |
| Boehringer Ingelheim Canada Ltd.ltee | 16 | $2,883 |
| Kyowa Kirin, Inc. | 20 | $985 |
| Arcutis Biotherapeutics, Inc. | 13 | $596 |
| UCB, Inc. | 3 | $329 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $301 |
| Johnson & Johnson | 2 | $230 |
| Mallinckrodt Hospital Products Inc. | 2 | $166 |
| Therakos LLC | 2 | $164 |
| Lilly USA, LLC | 2 | $158 |
| Janssen Scientific Affairs, LLC | 1 | $136 |
| Dermira, Inc. | 1 | $122 |
| Dermavant Sciences, Inc. | 1 | $118 |
| Krystal Biotech Inc | 1 | $117 |
| Nobelpharma America, LLC | 2 | $117 |
| Organogenesis Inc. | 1 | $114 |
| Mayne Pharma Commercial LLC | 1 | $113 |
| Mallinckrodt Enterprises LLC | 1 | $102 |
| E.r. Squibb & Sons, L.L.C. | 1 | $98 |
| LEO Pharma Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,227,580 in reported general payments places this provider in the 95th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 23 | $84,090 |
| XolairOmalizumab | 12 | $44,095 |
| Tacrolimus | 14 | $1,821 |
| Ketoconazole | 55 | $1,181 |
| Clobetasol Propionate | 21 | $877 |
| Fluocinonide | 13 | $560 |
| Dapsone | 15 | $408 |
| Triamcinolone Acetonide | 21 | $406 |
| Hydroxyzine Hcl | 11 | $125 |
| Hydrocortisone | 11 | $100 |
| Prednisone | 11 | $5 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$1.1M
- Julie Bowman LoweOklahoma City$227K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Stacie RougasOklahoma City$50K
- Clifford HendersonOklahoma City$45K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.